We employed BFA1 to inhibit autophagosome–lysosome fusion (Mauvezin and Neufeld, 2015) and CBE to mimic the effect of GBA1 mutations, which causes Gaucher’s disease and predisposition to Parkinson's disease. Here, GBA1 is linked to Parkinson disease.